Craft

Plus Therapeutics

Stock Price

$1.7

2024-04-18

Market Capitalization

$7.4 M

2024-04-18

Revenue

$224 K

FY, 2022

Plus Therapeutics Summary

Company Summary

Overview
Plus Therapeutics (formerly known as Cytori Therapeutics) is a pharmaceutical company focused on the discovery, development, and manufacturing of treatments for patients battling cancer and other life-threatening diseases. The company delivers a range of drugs using liposomal encapsulation technology.
Type
Public
Status
Active
Founded
1996
HQ
Austin, TX, US | view all locations
Website
http://www.plustherapeutics.com
Cybersecurity rating
Sectors

Key People

  • Marc Hedrick, President and CEO

    • Andrew Sims, Vice President and Chief Financial Officer

    • Cheri Rice, Vice President, Product Development

    • Norman Lafrance, Chief Medical Officer and Senior Vice President

      LocationsView all

      2 locations detected

      • Austin, TX HQ

        United States

        4200 Marathon Blvd #200

      • San Antonio, TX

        United States

        12500 Network Blvd

      Plus Therapeutics Financials

      Summary Financials

      Net income (FY, 2023)
      ($13.3M)
      Cash (FY, 2023)
      $8.6M
      EBIT (FY, 2023)
      ($13.3M)

      Footer menu